Empyrean Capital Partners’s RXO RXO Stock Holding History

Empyrean Capital Partners’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-816,497	Closed	-$14M	–	95
2022 Q4	$14M	Buy	+816,497	New	+$14.5M	0.44%	59

Other funds holding RXO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Empyrean Capital Partners's RXO Position: Q1 2023 in Review

Empyrean Capital Partners sold out of RXO (RXO) in Q1 2023, closing a stake of 816,497 shares — an estimated $14M sold.

Empyrean Capital Partners first reported a position in RXO in Q4 2022 and held it in 1 quarter. The position peaked at $14M in Q4 2022. 281 funds tracked by Wall St. Rank hold RXO as of Q1 2023.

Empyrean Capital Partners reported no remaining RXO position as of Q1 2023 after selling out during the quarter.
Empyrean Capital Partners sold 816,497 RXO shares in Q1 2023, an estimated $14M.
Empyrean Capital Partners first reported a position in RXO in Q4 2022 and held it in 1 quarter.
Empyrean Capital Partners's RXO position peaked at $14M in Q4 2022.
281 funds tracked by Wall St. Rank held RXO as of Q1 2023.

Based on Empyrean Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.